1887

Abstract

SUMMARY

Treatment of Epstein-Barr virus-determined nuclear antigen (EBNA) with DNA resulted in blocking of its ability to convert acid-fixed EBNA-negative cell nuclei to an EBNA-positive form. Epstein-Barr virus (EBV) DNA, herpes simplex virus type 2 (HSV-2) DNA and DNA isolated from three lymphoblastoid cell lines differed in their potency to block this reaction. EBV DNA was found to be about three times more effective than cellular DNAs in abolishing the ability of DNA-cellulose-purified EBNA to convert acid-fixed nuclei to the EBNA-positive form; the effect of HSV-2 DNA was of intermediate character. No difference was found between the blocking potency of DNAs isolated from EBV-genome-negative Ramos cells and EBV-genome-positive Raji and P3HR-1 cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-44-3-849
1979-09-01
2024-07-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/44/3/JV0440030849.html?itemId=/content/journal/jgv/10.1099/0022-1317-44-3-849&mimeType=html&fmt=ahah

References

  1. Baron D., Strominger J. L. 1978; Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen. Journal of Biological Chemistry 253:2875–2881
    [Google Scholar]
  2. Hirsch L., Roubal J., Vonka V. 1976; Replicating DNA of herpes simplex virus type I. Intervirology 7:I55–I75
    [Google Scholar]
  3. Hirsch I., Suchánková A., Závadová H., Vonka V. 1978; Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei. International Journal of Cancer 22:535–541
    [Google Scholar]
  4. Luka J., Siegert W., Klein G. 1977; Solubilization of the Epstein-Barr virus determined nuclear antigen and its characterization as a DNA-binding protein. Journal of Virology 22:1–8
    [Google Scholar]
  5. Luka J., Lindahl T., Klein G. 1978; Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cells lines. Journal of Virology 27:604–611
    [Google Scholar]
  6. Ohno S., Luka J., Lindahl T., Klein G. 1977; Identification of a purified complement-fixing antigen as the Epstein-Barr virus-determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proceedings of the National Academy of Sciences of the United States of America 74:1605–1609
    [Google Scholar]
  7. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein-Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
  8. Rigbv P. W. J., Dieckmann M., Rhodes C., Berg P. 1977; Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA Polymerase I. Journal of Molecular Biology 113:237–251
    [Google Scholar]
  9. Yajima Y., Nonoyama M. 1976; Mechanisms of infection with Epstein-Barr virus I. Viral DNA replication and formation of non-infectious virus particles in superinfected Raji cells. Journal of Virology 19:187–194
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-44-3-849
Loading
/content/journal/jgv/10.1099/0022-1317-44-3-849
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error